Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Journal of Immunology Research|January 22, 2019
TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome PatientsAdrianos Nezos, Eliona Gkioka, Michael Koutsilieris, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 31, 2007
Analysis of SAA1 gene polymorphisms in the Greek population: rheumatoid arthritis and FMF patients relative to normal controls. Homogeneous distribution and low incidence of AA amyloidosisClio P Mavragani, Nikos Yiannakouris, Elias Zintzaras, et al.
Arthritis Care & Research|August 29, 2015
Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic AssociationsTheofanis Karageorgas, Sofia Fragioudaki, Adrianos Nezos, et al.
Journal of Autoimmunity|October 28, 2017
Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymesClio P Mavragani, Adrianos Nezos, Irina Sagalovskiy, et al.
Rheumatology (Oxford, England)|March 7, 2019
Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjögren's syndromeSofie L M Blokland, Christina-Maria Flessa, Joel A G van Roon, et al.
Clinical Immunology (Orlando, Fla.)|October 23, 2019
Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndromeChristina-Maria Flessa, Stelios Vlachiotis, Adrianos Nezos, et al.
Frontiers in Medicine|April 4, 2022
Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease OutcomesVasiliki E Georgakopoulou, Panagiotis Lembessis, Charalampos Skarlis, et al.
Clinical and Experimental Rheumatology|May 31, 2018
Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndromeChristos F Kampolis, Sofia Fragkioudaki, Clio P Mavragani, et al.
Clinical and Experimental Rheumatology|July 29, 2014
IgG4-related disease: a rheumatologist's perspectiveFotini Soliotis, Clio P Mavragani, Sotiris C Plastiras, et al.
Seminars in Arthritis and Rheumatism|May 27, 2022
Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?Nikolaos Marketos, Vasiliki Koulouri, Evangelia P Piperi, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Journal of Immunology Research|January 22, 2019
TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome PatientsAdrianos Nezos, Eliona Gkioka, Michael Koutsilieris, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 31, 2007
Analysis of SAA1 gene polymorphisms in the Greek population: rheumatoid arthritis and FMF patients relative to normal controls. Homogeneous distribution and low incidence of AA amyloidosisClio P Mavragani, Nikos Yiannakouris, Elias Zintzaras, et al.
Arthritis Care & Research|August 29, 2015
Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic AssociationsTheofanis Karageorgas, Sofia Fragioudaki, Adrianos Nezos, et al.
Journal of Autoimmunity|October 28, 2017
Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymesClio P Mavragani, Adrianos Nezos, Irina Sagalovskiy, et al.
Rheumatology (Oxford, England)|March 7, 2019
Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjögren's syndromeSofie L M Blokland, Christina-Maria Flessa, Joel A G van Roon, et al.
Clinical Immunology (Orlando, Fla.)|October 23, 2019
Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndromeChristina-Maria Flessa, Stelios Vlachiotis, Adrianos Nezos, et al.
Frontiers in Medicine|April 4, 2022
Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease OutcomesVasiliki E Georgakopoulou, Panagiotis Lembessis, Charalampos Skarlis, et al.
Clinical and Experimental Rheumatology|May 31, 2018
Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndromeChristos F Kampolis, Sofia Fragkioudaki, Clio P Mavragani, et al.
Clinical and Experimental Rheumatology|July 29, 2014
IgG4-related disease: a rheumatologist's perspectiveFotini Soliotis, Clio P Mavragani, Sotiris C Plastiras, et al.
Seminars in Arthritis and Rheumatism|May 27, 2022
Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?Nikolaos Marketos, Vasiliki Koulouri, Evangelia P Piperi, et al.
Pageof 12